Published in Am J Clin Oncol on February 01, 2011
Considerations for observational research using large data sets in radiation oncology. Int J Radiat Oncol Biol Phys (2014) 2.06
Endoscopic management of benign tracheobronchial tumors. J Thorac Dis (2011) 1.21
Primary small cell cancer of cervical trachea: a case report and literature review. Int J Clin Exp Pathol (2015) 0.89
Anesthesia in an adult patient with tracheal hemangiomas: one-lung ventilation for lung lobectomy. J Anesth (2011) 0.88
Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database. Oncotarget (2016) 0.79
Primary tracheal adenocystic carcinoma and tracheal tumors during pregnancy. Rare Tumors (2011) 0.78
Synchronous primary cancers of trachea and esophagus and ventricular tachycardia. Chin J Cancer Res (2014) 0.78
A case of tracheal adenoid cystic carcinoma in a worker exposed to rubber fumes. Ann Occup Environ Med (2013) 0.78
Endobronchial laser ablation in the management of epithelial-myoepithelial carcinoma of the trachea. Respir Med Case Rep (2015) 0.77
Tracheal squamous cell carcinoma (SCC) metastatic to the skin in a patient on a checkpoint inhibitor. JAAD Case Rep (2015) 0.75
Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms. Radiol Oncol (2016) 0.75
Evaluation of airway resistance in primary small cell carcinoma of the trachea by MostGraph: a case study. J Thorac Dis (2016) 0.75
All that wheezes is not asthma. BMJ Case Rep (2014) 0.75
Sarcomatoid carcinoma in the trachea: A case report and literature review. Thorac Cancer (2017) 0.75
Adenoid Cystic Carcinoma of Trachea. Indian J Surg (2016) 0.75
Tracheal resection and reconstruction for malignant disease. J Thorac Dis (2016) 0.75
Metachronous tracheal squamous cell carcinoma treated with Nd: YAG laser. Respirol Case Rep (2015) 0.75
Primary malignant melanoma of the trachea: A case report. Oncol Lett (2014) 0.75
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Diagnosis and management of mycosis fungoides. Oncology (Williston Park) (2010) 2.32
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) (2012) 2.29
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) (2010) 2.01
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Factors that determine academic versus private practice career interest in radiation oncology residents in the United States: results of a nationwide survey. Int J Radiat Oncol Biol Phys (2013) 1.97
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol (2010) 1.96
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94
The pathogenesis of mycosis fungoides. N Engl J Med (2004) 1.78
Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leuk Lymphoma (2006) 1.72
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol (2007) 1.70
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Management of mycosis fungoides: Part 2. Treatment. Oncology (Williston Park) (2003) 1.57
The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol (2005) 1.57
Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) (2011) 1.52
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care (2014) 1.50
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer J (2007) 1.46
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys (2005) 1.44
Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials. Cancer J (2006) 1.41
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J (2004) 1.39
In regard to "Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series." (Int J Radiat Oncol Biol Phys 2012;83:624-629). Int J Radiat Oncol Biol Phys (2012) 1.37
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood (2010) 1.34
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol (2002) 1.29
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.25
The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol (2010) 1.20
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer (2011) 1.19
Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18
Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer (2014) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol (2011) 1.16
Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16
Total skin electron beam radiotherapy for patients who have mycosis fungoides. Hematol Oncol Clin North Am (2003) 1.13
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys (2007) 1.11
Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff (Millwood) (2012) 1.09
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (2012) 1.06
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma. Arch Dermatol (2009) 1.06
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys (2012) 1.02
Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol (2004) 1.02
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. Int J Radiat Oncol Biol Phys (2005) 1.01
The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Int J Radiat Oncol Biol Phys (2012) 1.00
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol (2008) 0.97
The cost implications of prostate cancer screening in the Medicare population. Cancer (2013) 0.95
Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol (2015) 0.94
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol (2010) 0.94
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med (2014) 0.93
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res (2013) 0.93
Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk (2012) 0.92
Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma. Br J Ophthalmol (2009) 0.92
Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer (2012) 0.91
Cutaneous lymphoma. Curr Probl Cancer (2008) 0.91
Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys (2011) 0.91
Melanoma brain metastases: is it time to reassess the bias? Curr Probl Cancer (2011) 0.90
Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex. Am J Clin Oncol (2013) 0.90
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.90
Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions. Med Care (2013) 0.89
Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. Cancer Treat Rev (2010) 0.89
Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. J Clin Oncol (2008) 0.89
Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys (2012) 0.88
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys (2006) 0.87
Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis. Oncology (Williston Park) (2003) 0.87
Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Rev Anticancer Ther (2011) 0.87
Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival. J Clin Oncol (2007) 0.86
Complications of brain tumors and their treatment. Hematol Oncol Clin North Am (2012) 0.86
National Residency Matching Program (NRMP) results for radiation oncology: 2011 update. Int J Radiat Oncol Biol Phys (2012) 0.86
Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy. J Clin Oncol (2005) 0.86
A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.85
Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res (2004) 0.85
Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol (2014) 0.85
National residency matching program results for radiation oncology: 2012 update. Int J Radiat Oncol Biol Phys (2013) 0.85
A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys (2010) 0.84
A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol (2013) 0.84
Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. J Natl Cancer Inst (2014) 0.84
Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) (2005) 0.83
Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J (2004) 0.82
Testicular doses in image-guided radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys (2011) 0.82
Cutaneous lymphomas. Semin Radiat Oncol (2007) 0.82